Transarterial chemoembolization (TACE), a minimally invasive procedure for liver cancer, is an effective treatment strategy for patients with large, asymptomatic, or multifocal hepatocellular ...

SAN FRANCISCO -- An immuno-oncology (IO) regimen for intermediate-stage hepatocellular carcinoma (HCC) significantly extended treatment benefit versus transarterial chemoembolization (TACE), according ...

In this review we will discuss TACE, TAE and TOCE in detail. The TACE procedure consists of the injection of anticancer drugs mixed with or without lipiodol into the hepatic artery followed by the ...

Recently, it has been demonstrated that TACE improves survival compared with best supportive care in meta-analyses of randomized trials and in two individual clinical trials. However, although ...

Please provide your email address to receive an email when new articles are posted on . Postprocedural imaging showed 10% of patients had new portal vein thrombosis after transarterial ...

Please provide your email address to receive an email when new articles are posted on . Transcatheter arterial chemoembolization alone and with microwave ablation yielded comparable overall survival ...

Randomized phase II trial of TACE plus everolimus as first-line therapy in localized unresectable hepatocellular carcinoma (HCC): The TRACER trial. Background: TACE is regarded as the standard of care ...

Doctors in Delhi successfully treated liver cancer in a 72-year-old high-risk patient without surgery using a minimally invasive procedure. The cancer developed from long-ignored fatty liver disease ...

The use of a non-invasive procedure combined with Lenvima plus Tyvyt demonstrated safe and effective results in patients with liver cancer not eligible for surgical resection. Safe and effective ...